1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–504.
2. Cooper C, McAlindon T,Snow S et al. Mechanical and constitutional risk factors for symptomatic knee osteoarthritis: differences between medial tibiofemoral and patellofemoral disease. J. Rheumatol 1994; 21: 307–13.
3. Davis M, Ettinger W, Neuhaus J et. al. Correlates of knee pain among US adults with and without radiografic knee osteoarthritis. J Rheumatol 1992; 19: 1943–49.
4. Creamer P, Hochberg MC. Why does osteoarthritis of the knee hurt – sometimes? Br J Rheumatol 1997; 37: 726–28.
5. Adebowale A. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 2002; 23: 217–25.
6. Biggee BA. Human serum glucosamine and sulfate levels after ingestion of glucosamine sulfate. Arthritis Rheum 2004; 50: S657.
7. Baici A, Bradamante P. Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interaction 1984; 51: 1–11.
8. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000; 283: 1469–75.
9. Towheed TE, Maxwell L, Anastassiades TP et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005; 2: CD002946.
10. Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007; 56: 555–67.
11. Leeb BF, Schweitzer H, Montag K, Smolen JS. 
A meta-analysis of chondroitinsulfate in the treatment of osteoarthritis. Osteoarthritis Cartilage 1999; 7(Suppl A): abstr 130.
12. Bana G, Jamard B, Verrouil E, Mazieres B. Chondroitin sulfate in the management of hip and knee OA: an overview. Adv Pharmacol 2006; 53: 507–22.
13. Michel BA, Stucki G, Frey D et al. Chondroitin 4 and 6 sulfate in osteoarthritis of the knee: A randomized, controlled trial. Arthritis Rheum 2005; 52(3): 779–86.
14. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.Osteoarthritis Cartilage 1998; 6(Suppl A): 37–8.
15. Rovetta G, Monteforte P, Molfetta G, Balestra G. A two-years study of chondroitin suffate in erosive osteoarthritis of the hand: behavior of erosions, osteophytes, pain and hand dysfunction. Drug Exp Clin Res 2004; 30(1): 11–6.
16. Reginster JY, Deroisy R, Rovati LC et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 2001; 27: 251–6.
17. Pawelka K, Gatterova J, Olejarova M et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3 year, randomized, placebo-controlled, double-blind study. Arch Intern Med 2002; 162: 2113–23.
18. Poolsup N, Suthisisang C, Channark P, Kittikulsuth W. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother 2005; 39: 1080–87.
19. Lippielo L, Woodword J, Karpman D et al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr Rheum 1999; suppl. 42; 256.
20. Leffler CN, Phillipi AF, Leffter SG et al. Glucosamine, chondroitin and magnaese ascorbate for degenerative joint disease of the knee or low back pain: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164: 85–91.
21. Shanklad WE. The effects of glucosamine and chondroitin sulfate on osteoarthritis of the TMJ: a preliminary report of 50 patients. Cranio 1998; 16: 230–5.
22. Clegg DO, Reda DJ, Harris CL et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 2006; 354(8): 795–808.
23. Fidelix TSA, Soares BGDO, Trevisani VF M. Diacerein for osteoarthritis. The Cochrane Database of Systematic Reviews 2006.
24. Christensen R, Bartels EM, Astrup A, Bliddal H. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials Osteoarthritis Cartilage 2007; 18042410 (P,S,E,B,D).
25. Lequesne M, Maheu E, Cadet C et al. Structural effect of avocado/soybean unsopanifiables on joint space loss in osteoarthritis of hip. Arthritis Care Research 2002; 47: 50–8.
26. Bruyere O, Burlet N, Delmas P et al. Evaluation of Symptomatic Slow-Acting Drugs in Osteoarthritis Using the GRADE System. BMC Musculoskelet Disord, 2008.

Л.И.Алексеева